| review article | Q7318358 |
| scholarly article | Q13442814 |
| P50 | author | Robert Lefkowitz | Q80910 |
| P2093 | author name string | Erin J Whalen | |
| Keshava Rajagopal | |||
| P2860 | cites work | Beta-arrestin-dependent formation of beta2 adrenergic receptor-Src protein kinase complexes | Q22008730 |
| A nuclear function of beta-arrestin1 in GPCR signaling: regulation of histone acetylation and gene transcription | Q24297869 | ||
| Association of beta-arrestin and TRAF6 negatively regulates Toll-like receptor-interleukin 1 receptor signaling | Q24299892 | ||
| {beta}-Arrestin is crucial for ubiquitination and down-regulation of the insulin-like growth factor-1 receptor by acting as adaptor for the MDM2 E3 ligase | Q24301549 | ||
| beta-Arrestin: a protein that regulates beta-adrenergic receptor function | Q24305145 | ||
| An Akt/beta-arrestin 2/PP2A signaling complex mediates dopaminergic neurotransmission and behavior | Q24310712 | ||
| Beta-arrestin 2 mediates endocytosis of type III TGF-beta receptor and down-regulation of its signaling | Q24320156 | ||
| beta-Arrestin 1 and Galphaq/11 coordinately activate RhoA and stress fiber formation following receptor stimulation | Q24324243 | ||
| Identification of beta-arrestin2 as a G protein-coupled receptor-stimulated regulator of NF-kappaB pathways | Q24338654 | ||
| beta-Arrestins bind and decrease cell-surface abundance of the Na+/H+ exchanger NHE5 isoform | Q24556620 | ||
| Nicotine induces cell proliferation by beta-arrestin-mediated activation of Src and Rb-Raf-1 pathways | Q34803242 | ||
| The ins and outs of G protein-coupled receptor trafficking | Q35183866 | ||
| The new face of active receptor bound arrestin attracts new partners | Q35214608 | ||
| Beta-arrestin-2 regulates the development of allergic asthma | Q35242857 | ||
| Regulation of G protein-coupled receptor endocytosis by ARF6 GTP-binding proteins | Q36021503 | ||
| Beta-arrestin-mediated activation of MAPK by inverse agonists reveals distinct active conformations for G protein-coupled receptors | Q36160942 | ||
| Visual and both non-visual arrestins in their "inactive" conformation bind JNK3 and Mdm2 and relocalize them from the nucleus to the cytoplasm | Q36726881 | ||
| The proliferative and antiapoptotic effects of substance P are facilitated by formation of a beta -arrestin-dependent scaffolding complex | Q37273521 | ||
| beta-arrestin-1 competitively inhibits insulin-induced ubiquitination and degradation of insulin receptor substrate 1. | Q37527105 | ||
| Receptor activity-independent recruitment of betaarrestin2 reveals specific signalling modes | Q40251292 | ||
| Opposing effects of beta-arrestin1 and beta-arrestin2 on activation and degradation of Src induced by protease-activated receptor 1. | Q40297494 | ||
| Distinct beta-arrestin- and G protein-dependent pathways for parathyroid hormone receptor-stimulated ERK1/2 activation. | Q40313388 | ||
| Receptor-specific ubiquitination of beta-arrestin directs assembly and targeting of seven-transmembrane receptor signalosomes. | Q40460839 | ||
| Constitutive protease-activated receptor-2-mediated migration of MDA MB-231 breast cancer cells requires both beta-arrestin-1 and -2. | Q40503317 | ||
| Differential desensitization, receptor phosphorylation, beta-arrestin recruitment, and ERK1/2 activation by the two endogenous ligands for the CC chemokine receptor 7. | Q40571692 | ||
| Reciprocal regulation of angiotensin receptor-activated extracellular signal-regulated kinases by beta-arrestins 1 and 2. | Q40601346 | ||
| Regulation of V2 vasopressin receptor degradation by agonist-promoted ubiquitination | Q40636866 | ||
| Beta-arrestin2 is critically involved in CXCR4-mediated chemotaxis, and this is mediated by its enhancement of p38 MAPK activation | Q40699131 | ||
| Phosphorylation of beta-arrestin2 regulates its function in internalization of beta(2)-adrenergic receptors | Q40709874 | ||
| Differential affinities of visual arrestin, beta arrestin1, and beta arrestin2 for G protein-coupled receptors delineate two major classes of receptors | Q40889383 | ||
| beta-arrestins regulate interleukin-8-induced CXCR1 internalization | Q40951707 | ||
| Differential nucleocytoplasmic shuttling of beta-arrestins. Characterization of a leucine-rich nuclear export signal in beta-arrestin2. | Q44094517 | ||
| β-Arrestin1 Mediates Insulin-like Growth Factor 1 (IGF-1) Activation of Phosphatidylinositol 3-Kinase (PI3K) and Anti-apoptosis | Q44610984 | ||
| Arrestins block G protein-coupled receptor-mediated apoptosis | Q44820320 | ||
| Insulin-induced beta-arrestin1 Ser-412 phosphorylation is a mechanism for desensitization of ERK activation by Galphai-coupled receptors | Q45133871 | ||
| Regulation of Notch signalling by non-visual beta-arrestin | Q45345847 | ||
| Molecular switches involving the AP-2 beta2 appendage regulate endocytic cargo selection and clathrin coat assembly | Q45345954 | ||
| Nonvisual arrestin oligomerization and cellular localization are regulated by inositol hexakisphosphate binding | Q46913508 | ||
| Beta-arrestin 2 regulates zebrafish development through the hedgehog signaling pathway | Q47073322 | ||
| The stability of the G protein-coupled receptor-beta-arrestin interaction determines the mechanism and functional consequence of ERK activation | Q50335944 | ||
| Arrestin-mediated ERK activation by gonadotropin-releasing hormone receptors: receptor-specific activation mechanisms and compartmentalization | Q50746717 | ||
| A molecular pathway for light-dependent photoreceptor apoptosis in Drosophila. | Q52584174 | ||
| Heart failure | Q53998058 | ||
| The role of receptor kinases and arrestins in G protein-coupled receptor regulation | Q74578170 | ||
| G protein-coupled receptor kinases | Q77366588 | ||
| Arrestin serves as a molecular switch, linking endogenous alpha2-adrenergic receptor to SRC-dependent, but not SRC-independent, ERK activation | Q79815563 | ||
| Platelet-activating factor-induced clathrin-mediated endocytosis requires beta-arrestin-1 recruitment and activation of the p38 MAPK signalosome at the plasma membrane for actin bundle formation | Q83367366 | ||
| Activation and targeting of extracellular signal-regulated kinases by beta-arrestin scaffolds | Q24605173 | ||
| Crystal structure of beta-arrestin at 1.9 A: possible mechanism of receptor binding and membrane Translocation | Q27634946 | ||
| X-ray crystal structure of arrestin from bovine rod outer segments | Q27748911 | ||
| Beta-arrestin 2: a receptor-regulated MAPK scaffold for the activation of JNK3 | Q28138462 | ||
| Feedback regulation of beta-arrestin1 function by extracellular signal-regulated kinases | Q28144769 | ||
| Regulation of receptor fate by ubiquitination of activated beta 2-adrenergic receptor and beta-arrestin | Q28190513 | ||
| Regulation of arrestin-3 phosphorylation by casein kinase II | Q28205089 | ||
| Dishevelled 2 recruits beta-arrestin 2 to mediate Wnt5A-stimulated endocytosis of Frizzled 4 | Q28205234 | ||
| Beta-arrestin 2 functions as a G-protein-coupled receptor-activated regulator of oncoprotein Mdm2 | Q28218131 | ||
| Transduction of receptor signals by beta-arrestins | Q28246395 | ||
| The Hedgehog response network: sensors, switches, and routers | Q28267648 | ||
| Activity-dependent internalization of smoothened mediated by beta-arrestin 2 and GRK2 | Q28299947 | ||
| beta -Arrestin-mediated recruitment of the Src family kinase Yes mediates endothelin-1-stimulated glucose transport | Q28512887 | ||
| Insulin induces heterologous desensitization of G-protein-coupled receptor and insulin-like growth factor I signaling by downregulating beta-arrestin-1. | Q28575441 | ||
| Targeting of cyclic AMP degradation to beta 2-adrenergic receptors by beta-arrestins | Q28578546 | ||
| A beta-arrestin-dependent scaffold is associated with prolonged MAPK activation in pseudopodia during protease-activated receptor-2-induced chemotaxis | Q28592370 | ||
| G proteins: transducers of receptor-generated signals | Q29547519 | ||
| Seven-transmembrane receptors | Q29619896 | ||
| Activation-dependent conformational changes in {beta}-arrestin 2. | Q33208189 | ||
| Functional antagonism of different G protein-coupled receptor kinases for beta-arrestin-mediated angiotensin II receptor signaling | Q33819399 | ||
| Different G protein-coupled receptor kinases govern G protein and beta-arrestin-mediated signaling of V2 vasopressin receptor | Q33819496 | ||
| Arrestin-related proteins mediate pH signaling in fungi. | Q33922905 | ||
| Defective lymphocyte chemotaxis in beta-arrestin2- and GRK6-deficient mice. | Q34064133 | ||
| The neurobiology of slow synaptic transmission | Q34100272 | ||
| Phosphoserine/threonine-binding domains | Q34180612 | ||
| Membrane trafficking of G protein-coupled receptors | Q34292577 | ||
| Role of beta-arrestin 1 in the metastatic progression of colorectal cancer | Q34335080 | ||
| Functional desensitization of the isolated beta-adrenergic receptor by the beta-adrenergic receptor kinase: potential role of an analog of the retinal protein arrestin (48-kDa protein) | Q34376629 | ||
| beta-Arrestin inhibits NF-kappaB activity by means of its interaction with the NF-kappaB inhibitor IkappaBalpha. | Q34513767 | ||
| Independent beta-arrestin 2 and G protein-mediated pathways for angiotensin II activation of extracellular signal-regulated kinases 1 and 2. | Q34536660 | ||
| Differential kinetic and spatial patterns of beta-arrestin and G protein-mediated ERK activation by the angiotensin II receptor | Q34548751 | ||
| beta-arrestin-dependent, G protein-independent ERK1/2 activation by the beta2 adrenergic receptor | Q34562493 | ||
| Cooperative regulation of extracellular signal-regulated kinase activation and cell shape change by filamin A and beta-arrestins. | Q34564790 | ||
| beta-arrestins regulate mitogenic signaling and clathrin-mediated endocytosis of the insulin-like growth factor I receptor | Q34754993 | ||
| P433 | issue | 5 | |
| P921 | main subject | transmembrane protein | Q424204 |
| P304 | page(s) | 643-652 | |
| P577 | publication date | 2006-12-01 | |
| P1433 | published in | Molecular Cell | Q3319468 |
| P1476 | title | New roles for beta-arrestins in cell signaling: not just for seven-transmembrane receptors | |
| P478 | volume | 24 |
| Q80657778 | A crystal clear view of the beta2-adrenergic receptor |
| Q36691842 | A functional role for Anopheles gambiae Arrestin1 in olfactory signal transduction |
| Q39069074 | A genome-wide linkage scan in Tunisian families identifies a novel locus for non-syndromic posterior microphthalmia to chromosome 2q37.1. |
| Q39622751 | A kinase-independent role for unoccupied insulin and IGF-1 receptors in the control of apoptosis. |
| Q39954092 | A novel protein kinase A-independent, beta-arrestin-1-dependent signaling pathway for p38 mitogen-activated protein kinase activation by beta2-adrenergic receptors |
| Q45741993 | A novel receptor cross-talk between the ATP receptor P2Y2 and formyl peptide receptors reactivates desensitized neutrophils to produce superoxide |
| Q38089182 | A perspective on more effective GPCR-targeted drug discovery efforts. |
| Q38240756 | A-kinase anchoring proteins: cAMP compartmentalization in neurodegenerative and obstructive pulmonary diseases |
| Q89860579 | AGAP2: Modulating TGFβ1-Signaling in the Regulation of Liver Fibrosis |
| Q34577233 | ARRB1-mediated regulation of E2F target genes in nicotine-induced growth of lung tumors |
| Q34388776 | ARRB1/β-arrestin-1 mediates neuroprotection through coordination of BECN1-dependent autophagy in cerebral ischemia. |
| Q28541771 | Activation of mu opioid receptors sensitizes transient receptor potential vanilloid type 1 (TRPV1) via β-arrestin-2-mediated cross-talk |
| Q41788382 | Alternative signaling: cardiomyocyte beta1-adrenergic receptors signal through EGFRs |
| Q28578913 | An adrenal beta-arrestin 1-mediated signaling pathway underlies angiotensin II-induced aldosterone production in vitro and in vivo |
| Q38004211 | An expanded family of arrestins regulate metabolism |
| Q90305559 | Angiotensin II Type 1 Receptor Autoantibodies in Primary Aldosteronism |
| Q42371966 | Angiotensin receptor blocker drugs and inhibition of adrenal beta-arrestin-1-dependent aldosterone production: Implications for heart failure therapy |
| Q48474978 | Antidepressant-induced differential ubiquitination of β-arrestins 1 and 2 in mononuclear leucocytes of patients with depression |
| Q33832471 | Arrestin and the multi-PDZ domain-containing protein MPZ-1 interact with phosphatase and tensin homolog (PTEN) and regulate Caenorhabditis elegans longevity |
| Q35565885 | Arrestin development: emerging roles for beta-arrestins in developmental signaling pathways |
| Q41865336 | Arrestin orchestrates crosstalk between G protein-coupled receptors to modulate the spatiotemporal activation of ERK MAPK. |
| Q43240938 | Arrestin-like proteins mediate ubiquitination and endocytosis of the yeast metal transporter Smf1. |
| Q24647492 | Arresting serotonin |
| Q37341630 | Arrestins as adaptors for ubiquitination in endocytosis and sorting |
| Q37321957 | Arrestins in host-pathogen interactions |
| Q28831166 | Autophagy-associated alpha-arrestin signaling is required for conidiogenous cell development in Magnaporthe oryzae |
| Q37166800 | Beta-Arrestin2 regulates RANKL and ephrins gene expression in response to bone remodeling in mice. |
| Q36964334 | Beta-arrestin 2 is required for lysophosphatidic acid-induced NF-kappaB activation |
| Q34654662 | Beta-arrestin-biased ligands at seven-transmembrane receptors |
| Q36983577 | Beta-arrestin-mediated localization of smoothened to the primary cilium |
| Q39782848 | Beta-arrestin-mediated signaling regulates protein synthesis. |
| Q30372475 | BiPS, a photocleavable, isotopically coded, fluorescent cross-linker for structural proteomics. |
| Q38440471 | Biased agonism: An emerging paradigm in GPCR drug discovery |
| Q34104805 | Both hematopoietic-derived and non-hematopoietic-derived {beta}-arrestin-2 regulates murine allergic airway disease |
| Q24321812 | CIN85 regulates dopamine receptor endocytosis and governs behaviour in mice |
| Q58600712 | CXCR7/CXCR4 heterodimer-induced histone demethylation: a new mechanism of colorectal tumorigenesis |
| Q90593525 | Cofilin, a Master Node Regulating Cytoskeletal Pathogenesis in Alzheimer's Disease |
| Q37919731 | Control of striatal signaling by g protein regulators |
| Q37145670 | Controlled-release carvedilol in the management of systemic hypertension and myocardial dysfunction |
| Q34285721 | Cooperation Between the Septins and the Actomyosin Ring and Role of a Cell-Integrity Pathway During Cell Division in Fission Yeast |
| Q36820191 | Deficiency of β-arrestin1 ameliorates collagen-induced arthritis with impaired TH17 cell differentiation. |
| Q37299072 | Designing heart performance by gene transfer. |
| Q37349092 | Down-regulation of β-arrestin2 promotes tumour invasion and indicates poor prognosis of hepatocellular carcinoma |
| Q51265394 | Downregulation of a GPCR by β-Arrestin2-Mediated Switch from an Endosomal to a TGN Recycling Pathway. |
| Q50652866 | Downregulation of β-arrestin 1 suppresses glioblastoma cell malignant progression vis inhibition of Src signaling |
| Q41071174 | Effects of chronic alcohol exposure on ischemia-reperfusion-induced acute kidney injury in mice: the role of β-arrestin 2 and glycogen synthase kinase 3. |
| Q36260340 | Effects of small platform catheter-based left ventricular assist device support on regional myocardial signal transduction. |
| Q37118269 | Efficient coupling of transducin to monomeric rhodopsin in a phospholipid bilayer |
| Q33356416 | Endocytic regulation of alkali metal transport proteins in mammals, yeast and plants |
| Q27937774 | Endocytosis of the Aspartic Acid/Glutamic Acid Transporter Dip5 Is Triggered by Substrate-Dependent Recruitment of the Rsp5 Ubiquitin Ligase via the Arrestin-Like Protein Aly2 |
| Q47113667 | Enhanced response of melanoma cells to MEK inhibitors following unbiased IGF-1R down-regulation |
| Q38847534 | Expression array analysis of the hepatocyte growth factor invasive program |
| Q37729297 | Fenoterol, a beta(2)-adrenoceptor agonist, inhibits LPS-induced membrane-bound CD14, TLR4/CD14 complex, and inflammatory cytokines production through beta-arrestin-2 in THP-1 cell line |
| Q33757282 | Fission yeast arrestin-related trafficking adaptor, Arn1/Any1, is ubiquitinated by Pub1 E3 ligase and regulates endocytosis of Cat1 amino acid transporter |
| Q42619195 | Functional antagonism of β-arrestin isoforms balance IGF-1R expression and signalling with distinct cancer-related biological outcomes. |
| Q24318455 | Functional specialization of beta-arrestin interactions revealed by proteomic analysis |
| Q26853233 | G Protein-Coupled Receptor Signaling in Stem Cells and Cancer |
| Q37881660 | G protein-coupled receptor kinases in normal and failing myocardium |
| Q36914223 | G protein-coupled receptor-promoted trafficking of Gbeta1gamma2 leads to AKT activation at endosomes via a mechanism mediated by Gbeta1gamma2-Rab11a interaction |
| Q64252945 | GRKs and β-Arrestins: "Gatekeepers" of Mitochondrial Function in the Failing Heart |
| Q36049271 | Genetic Deletion of β-Arrestin-2 and the Mitigation of Established Airway Hyperresponsiveness in a Murine Asthma Model |
| Q37277318 | HIV-1 gp120 primes lymphocytes for opioid-induced, beta-arrestin 2-dependent apoptosis |
| Q38186583 | Heart failure-specific changes in protein kinase signalling. |
| Q35693310 | In silico screening for agonists and blockers of the β(2) adrenergic receptor: implications of inactive and activated state structures |
| Q28571025 | In vitro hypoxia impairs beta2-adrenergic receptor signaling in primary rat alveolar epithelial cells |
| Q91778396 | In vivo flow cytometry combined with intravital microscopy to monitor kinetics of transplanted bone marrow mononuclear cells in peripheral blood and bone marrow |
| Q61796045 | Indispensable role of β-arrestin2 in the protection of remifentanil preconditioning against hepatic ischemic reperfusion injury |
| Q99629092 | Individual phosphorylation sites at the C-terminus of the apelin receptor play different roles in signal transduction |
| Q35609910 | Inhibition of EGF-induced ERK/MAP kinase-mediated astrocyte proliferation by mu opioids: integration of G protein and beta-arrestin 2-dependent pathways |
| Q37119883 | Internalization and desensitization of adenosine receptors |
| Q53503547 | Interrogating 7TM receptors: does texture in the question yield greater texture in the answer? |
| Q24643003 | Kappa opioids promote the proliferation of astrocytes via Gbetagamma and beta-arrestin 2-dependent MAPK-mediated pathways |
| Q35779987 | Ligand-induced internalization of the type 1 cholecystokinin receptor independent of recognized signaling activity |
| Q79888462 | Long-distance affair with adrenal GRK2 hangs up heart failure |
| Q34397201 | M3-muscarinic receptor promotes insulin release via receptor phosphorylation/arrestin-dependent activation of protein kinase D1. |
| Q35424798 | Mechanisms underlying acute protection from cardiac ischemia-reperfusion injury |
| Q28540099 | Modulation of Anopheles stephensi gene expression by nitroquine, an antimalarial drug against Plasmodium yoelii infection in the mosquito |
| Q34126537 | Molecular basis of lysophosphatidic acid-induced NF-κB activation |
| Q40024079 | Multiple roles for the C-terminal tail of the chemokine scavenger D6. |
| Q37380865 | Neurogenesis-dependent and -independent effects of fluoxetine in an animal model of anxiety/depression. |
| Q24658250 | Neurokinin 1 receptors regulate morphine-induced endocytosis and desensitization of mu-opioid receptors in CNS neurons |
| Q37590093 | Nicotinic receptors: allosteric transitions and therapeutic targets in the nervous system |
| Q38190099 | Non-canonical signalling and roles of the vasoactive peptides angiotensins and kinins. |
| Q90291856 | Novel high molecular weight albumin-conjugated angiotensin II activates β-arrestin and G-protein pathways |
| Q42146853 | Occupancy of human EPCR by protein C induces β-arrestin-2 biased PAR1 signaling by both APC and thrombin |
| Q47273596 | Oncogenic RAS-Induced Perinuclear Signaling Complexes Requiring KSR1 Regulate Signal Transmission to Downstream Targets |
| Q34581041 | Osteoblast regulation via ligand-activated nuclear trafficking of the oxytocin receptor |
| Q36911200 | Pharmacological onomastics: what's in a name? |
| Q27331560 | Polarization of migrating monocytic cells is independent of PI 3-kinase activity |
| Q92154971 | Possible association of arrestin domain-containing protein 3 and progression of non-alcoholic fatty liver disease |
| Q88208247 | Protease-activated receptor signalling by coagulation proteases in endothelial cells |
| Q39142718 | Protein kinase D links Gq-coupled receptors to cAMP response element-binding protein (CREB)-Ser133 phosphorylation in the heart |
| Q40815046 | Receptor-independent Ambient pH signaling by ubiquitin attachment to fungal arrestin-like PalF. |
| Q30010478 | Regulation of GPCR activity, trafficking and localization by GPCR-interacting proteins |
| Q36506527 | Regulation of mitochondrial oxidative stress by β-arrestins in cultured human cardiac fibroblasts |
| Q35604521 | Regulation of α(2B)-adrenergic receptor-mediated extracellular signal-regulated kinase 1/2 (ERK1/2) activation by ADP-ribosylation factor 1. |
| Q33975010 | Role for β-arrestin in mediating paradoxical β2AR and PAR2 signaling in asthma |
| Q42148785 | Role of Phosphorylation in the Control of Clathrin-Mediated Internalization of GPCR. |
| Q37070857 | S-nitrosylation of beta-arrestin regulates beta-adrenergic receptor trafficking |
| Q34402623 | Serotonin, but not N-methyltryptamines, activates the serotonin 2A receptor via a ß-arrestin2/Src/Akt signaling complex in vivo |
| Q33890786 | Seven transmembrane receptors as shapeshifting proteins: the impact of allosteric modulation and functional selectivity on new drug discovery |
| Q42722797 | Signalosomes: delivering cardioprotective signals from GPCRs to mitochondria |
| Q41416491 | Sorafenib targets dysregulated Rho kinase expression and portal hypertension in rats with secondary biliary cirrhosis |
| Q36252363 | Spinophilin as a novel regulator of M3 muscarinic receptor-mediated insulin release in vitro and in vivo |
| Q89847369 | Structure and function of β-arrestins, their emerging role in breast cancer, and potential opportunities for therapeutic manipulation |
| Q90862887 | Targeting cell signaling in allergic asthma |
| Q39916587 | The C-terminal tail of CRTH2 is a key molecular determinant that constrains Galphai and downstream signaling cascade activation |
| Q33927277 | The M3-muscarinic receptor regulates learning and memory in a receptor phosphorylation/arrestin-dependent manner |
| Q41193774 | The Neutrophil Response Induced by an Agonist for Free Fatty Acid Receptor 2 (GPR43) Is Primed by Tumor Necrosis Factor Alpha and by Receptor Uncoupling from the Cytoskeleton but Attenuated by Tissue Recruitment |
| Q27865233 | The action and mode of binding of thiazolidinedione ligands at free fatty acid receptor 1 |
| Q37236186 | The arrestin fold: variations on a theme |
| Q30561736 | The arrestin-domain containing protein AdcA is a response element to stress |
| Q40446331 | The beta-arrestin-2 scaffold protein promotes c-Jun N-terminal kinase-3 activation by binding to its nonconserved N terminus. |
| Q36539176 | The mechanism and function of mitogen-activated protein kinase activation by ARF1. |
| Q26801420 | The mechanism of μ-opioid receptor (MOR)-TRPV1 crosstalk in TRPV1 activation involves morphine anti-nociception, tolerance and dependence |
| Q35534233 | The somatostatin analog 188Re-P2045 inhibits the growth of AR42J pancreatic tumor xenografts |
| Q29614609 | The vertebrate primary cilium in development, homeostasis, and disease |
| Q59807304 | Therapeutic Targets for Treatment of Heart Failure: Focus on GRKs and β-Arrestins Affecting βAR Signaling |
| Q24628602 | Therapeutic potential for novel drugs targeting the type 1 cholecystokinin receptor |
| Q37375712 | Thioredoxin-independent regulation of metabolism by the alpha-arrestin proteins. |
| Q48129778 | Thyroid Hormone-Induced Differentiation of Astrocytes is Associated with Transcriptional Upregulation of β-arrestin-1 and β-adrenergic Receptor-Mediated Endosomal Signaling |
| Q34359955 | Tolerance to the Antinociceptive Effect of Morphine in the Absence of Short-Term Presynaptic Desensitization in Rat Periaqueductal Gray Neurons |
| Q59336003 | Tonic ATP-mediated growth suppression in peripheral nerve glia requires arrestin-PP2 and is evaded in NF1 |
| Q36887422 | Trafficking of the Menkes copper transporter ATP7A is regulated by clathrin-, AP-2-, AP-1-, and Rab22-dependent steps |
| Q42826128 | Tumor necrosis factor receptor-1 can function through a G alpha q/11-beta-arrestin-1 signaling complex |
| Q36755025 | Ubiquitin-specific Protease 20 Regulates the Reciprocal Functions of β-Arrestin2 in Toll-like Receptor 4-promoted Nuclear Factor κB (NFκB) Activation |
| Q36411260 | Ubiquitination of beta-arrestin links seven-transmembrane receptor endocytosis and ERK activation |
| Q33942342 | Vascular signaling through G protein-coupled receptors: new concepts |
| Q41917803 | beta-Arrestin-biased agonism of the angiotensin receptor induced by mechanical stress |
| Q33840022 | beta-Arrestin-dependent activation of Ca(2+)/calmodulin kinase II after beta(1)-adrenergic receptor stimulation |
| Q24654027 | beta-Arrestin1 mediates nicotinic acid-induced flushing, but not its antilipolytic effect, in mice |
| Q36156773 | beta-arrestin 2 oligomerization controls the Mdm2-dependent inhibition of p53. |
| Q40034384 | beta-arrestin-biased agonism at the beta2-adrenergic receptor |
| Q37551918 | β-Adrenergic Receptor and Insulin Resistance in the Heart |
| Q95834242 | β-Adrenergic receptor structure and function: molecular insights guiding the development of novel therapeutic strategies to treat malignancy |
| Q38015368 | β-Adrenoceptor Signaling Networks in Adipocytes for Recruiting Stored Fat and Energy Expenditure |
| Q34044736 | β-Arrestin 2 negatively regulates Toll-like receptor 4 (TLR4)-triggered inflammatory signaling via targeting p38 MAPK and interleukin 10. |
| Q59805371 | β-Arrestin Based Receptor Signaling Paradigms: Potential Therapeutic Targets for Complex Age-Related Disorders |
| Q34619611 | β-Arrestin-1 links mitogenic sonic hedgehog signaling to the cell cycle exit machinery in neural precursors |
| Q33985855 | β-Arrestin-2 deficiency attenuates abdominal aortic aneurysm formation in mice |
| Q30448011 | β-Arrestin-2 desensitizes the transient receptor potential vanilloid 1 (TRPV1) channel |
| Q41453724 | β-Arrestin-2 inhibits preference for alcohol in mice and suppresses Akt signaling in the dorsal striatum |
| Q35426493 | β-Arrestin-dependent deactivation of mouse melanopsin. |
| Q35175384 | β-Arrestin-mediated receptor trafficking and signal transduction |
| Q33808587 | β-Arrestin1 mediates the endocytosis and functions of macrophage migration inhibitory factor |
| Q34716806 | β-Arrestin: A signaling molecule and potential therapeutic target for heart failure |
| Q34603394 | β-Arrestins regulate human cardiac fibroblast transformation and collagen synthesis in adverse ventricular remodeling |
| Q37810522 | β-Arrestins: multifunctional signaling adaptors in type 2 diabetes |
| Q64922148 | β-arrestin 1 Overexpression Increases Temozolomide Resistance in Human Malignant Glioma Cells. |
| Q60932658 | β-arrestin 1 regulates β2-adrenergic receptor-mediated skeletal muscle hypertrophy and contractility |
| Q24297887 | β-arrestin Kurtz inhibits MAPK and Toll signalling in Drosophila development |
| Q35214338 | β-arrestin regulates estradiol membrane-initiated signaling in hypothalamic neurons |
| Q90711266 | β-arrestin-2 enhances intestinal epithelial apoptosis in necrotizing enterocolitis |
| Q34039598 | β-arrestin-2-biased agonism of delta opioid receptors sensitizes transient receptor potential vanilloid type 1 (TRPV1) in primary sensory neurons |
| Q24306884 | β-arrestin1 mediates metastatic growth of breast cancer cells by facilitating HIF-1-dependent VEGF expression |
| Q35741012 | β-arrestin1 over-expression is associated with an unfavorable prognosis in lung adenocarcinomas and correlated with vascular endothelial growth factor |
| Q54117203 | β-arrestin2 Affects Cardiac Progenitor Cell Survival through Cell Mobility and Tube Formation in Severe Hypoxia. |
| Q36756664 | β2-adrenergic receptor activation prevents rodent dopaminergic neurotoxicity by inhibiting microglia via a novel signaling pathway |
Search more.